| PUBCHEM ID |
121248338
|
| UNII |
BC7E3S0RGA
|
| Preferred Term |
N6-((S)-4-CARBOXY-4-PALMITAMIDOBUTANOYL)-L-LYSINE
|
| CAS |
1892583-15-1
|
| INCHIKEY |
RXIYDVPUGHWHNJ-GOTSBHOMSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCCCCCCCCCCCCC(N[C@@H](CCC(NCCCC[C@@H](C(O)=O)N)=O)C(O)=O)=O
|
| Total Surface Area |
441,1
|
| Relative PSA |
0,26423
|
| TPSA |
158,82
|
| cLogS |
-4,923
|
| MW |
513,717
|
| cLogP |
2,8929
|
| H-Acceptors |
9
|
| H-Donors |
5
|
| Ro5 violations |
1
|
| Druglikeness |
-43,633
|
| DrugScore |
0,262042551009171
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,1552
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
2,2111
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
-0,1438
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
1,869
|
| Carcinogenicity (Three-class) |
Non-required
|
